Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% Dual Inactivation and Filtration (DIF) in Participants With Post-polio Syndrome
Clinical trial NCT02176863 · TERMINATED
Trial details
- NCT number
- NCT02176863
- Sponsor
- Instituto Grifols, S.A.
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-23
- Primary completion
- 2022-11-24
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.